Patents by Inventor Matthew Olding HEBB

Matthew Olding HEBB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230113275
    Abstract: The present invention relates to a method of producing expandable cultured brain cells. The brain cells are neurotrophic factor (NTF) positive. The expandable cultured brain cells are obtained by culturing a biopsy obtained from the cortical and/or subcortical brain region of a living subject. The biopsies can be obtained during neurosurgical procedures such as deep brain stimulation. The expandable cultured brain cells of the present invention are useful for the treatment of neurological diseases and other medical conditions.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 13, 2023
    Applicant: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventor: Matthew Olding HEBB
  • Patent number: 11167133
    Abstract: An intratumoral modulation therapy (IMT) method for the treatment of nervous system and systemic tumor in a patient which includes: (a) chronically implanting an electrode adjacent to or in the tumor of the patient or in a residual tumor bed, the electrode having electrical leads connected thereto; and (b) generating electric stimulation and applying the electric stimulation through the electrical leads to the electrode adjacent to or within the tumor. A method of transferring genetic material to a tumor cell which includes: (a) positioning an electrode adjacent to the tumor cell, the electrode having electrical leads connected thereto; (b) generating electric stimulation and applying the electric stimulation through the electrical leads to the electrode adjacent the cancer cell; and (c) delivering the genetic material to the tumor cell treated with the continuous alternating electric stimulation.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: November 9, 2021
    Assignee: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventors: Matthew Olding Hebb, Susanne Schmid
  • Publication number: 20200181569
    Abstract: The present invention relates to a method of producing expandable cultured brain cells. The brain cells are neurotrophic factor (NTF) positive. The expandable cultured brain cells are obtained by culturing a biopsy obtained from the cortical and/or subcortical brain region of a living subject. The biopsies can be obtained during neurosurgical procedures such as deep brain stimulation. The expandable cultured brain cells of the present invention are useful for the treatment of neurological diseases and other medical conditions.
    Type: Application
    Filed: February 11, 2020
    Publication date: June 11, 2020
    Applicant: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventor: Matthew Olding HEBB
  • Publication number: 20180289954
    Abstract: An intratumoral modulation therapy (IMT) method for the treatment of nervous system and systemic tumor in a patient which includes: (a) chronically implanting an electrode adjacent to or in the tumor of the patient or in a residual tumor bed, the electrode having electrical leads connected thereto; and (b) generating electric stimulation and applying the electric stimulation through the electrical leads to the electrode adjacent to or within the tumor. A method of transferring genetic material to a tumor cell which includes: (a) positioning an electrode adjacent to the tumor cell, the electrode having electrical leads connected thereto; (b) generating electric stimulation and applying the electric stimulation through the electrical leads to the electrode adjacent the cancer cell; and (c) delivering the genetic material to the tumor cell treated with the continuous alternating electric stimulation.
    Type: Application
    Filed: May 16, 2016
    Publication date: October 11, 2018
    Inventors: Matthew Olding HEBB, Susanne SCHMID
  • Publication number: 20160115445
    Abstract: The present invention relates to a method of producing expandable cultured brain cells. The brain cells are neurotrophic factor (NTF) positive. The expandable cultured brain cells are obtained by culturing a biopsy obtained from the cortical and/or subcortical brain region of a living subject. The biopsies can be obtained during neurosurgical procedures such as deep brain stimulation. The expandable cultured brain cells of the present invention are useful for the treatment of neurological diseases and other medical conditions.
    Type: Application
    Filed: May 16, 2014
    Publication date: April 28, 2016
    Inventor: Matthew Olding HEBB